Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV005235474 | SCV001140784 | likely benign | Hereditary cancer | 2025-02-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following: it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease, and/or has normal protein function, and/or has lack of segregation with disease, and/or has been detected in co-occurrence with known pathogenic variant, and/or has lack of disease association in case-control studies, and/or is located in a region inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002067002 | SCV002415799 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2023-09-21 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000990021 | SCV005404906 | benign | Familial cancer of breast | 2024-08-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |